The Role of Cyclooxygenase-2 (COX-2) in Inflammatory Bone Resorption

Journal of Endodontics

Volumn 33, Issue 4, 2007, Pages 432-436

  Coon, David ^a   Gulati, Ajay ^a   Cowan, Cameron ^a   He, Jianing ^a  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

Cyclooxygenase 2; inflammation; osteoclast; osteoprotegerin; receptor activator of NF B ligand

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; AH PLUS; ALUMINUM DERIVATIVE; AUTACOID; BIOLOGICAL MARKER; CALCIUM DERIVATIVE; CYCLOOXYGENASE 2; EPOXY RESIN; GUTTA PERCHA; ISOENZYME; LIPOPOLYSACCHARIDE; MINERAL TRIOXIDE AGGREGATE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; OXIDE; PROSTAGLANDIN E2; RESILON SEALER; ROOT CANAL FILLING MATERIAL; SILICATE; TARTRATE-RESISTANT ACID PHOSPHATASE; TNFRSF11B PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; DRUG COMBINATION; ENZYMOLOGY; FEMALE; MALE; METABOLISM; MOUSE; MOUSE MUTANT; OSTEITIS; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PHYSIOLOGY;

ACID PHOSPHATASE; ALUMINUM COMPOUNDS; ANIMALS; BIOLOGICAL MARKERS; BONE RESORPTION; CALCIUM COMPOUNDS; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; DRUG COMBINATIONS; EPOXY RESINS; FEMALE; GUTTA-PERCHA; INFLAMMATION MEDIATORS; ISOENZYMES; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT; OSTEITIS; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN; OXIDES; RANK LIGAND; ROOT CANAL FILLING MATERIALS; SILICATES;

EID: 33947128138     PISSN: 00992399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joen.2006.12.001     Document Type: Article

References (34)

1. Kakehashi S., Stanley H.R., and Fitzgerald R.J. The effects of surgical exposures of dental pulps in germ-free and conventional laboratory rats. Oral Surg Oral Med Oral Pathol 20 (1965) 340-349
2. Takahashi K. Microbiological, pathological, inflammatory, immunological and molecular biological aspects of periradicular disease. Int Endod J 31 (1998) 311-325
3. McCarthy J.A. Prostaglandins: an overview. Adv Pediatr 25 (1978) 121-149
4. Fung H.B., and Kirschenbaum H.L. Selective cyclooxygenase-2 inhibitors for the treatment of arthritis. Clin Ther 21 (1999) 1131-1157
5. Huang F.M., Chou M.Y., and Chang Y.C. Induction of cyclooxygenase-2 mRNA and protein expression by epoxy resin and zinc oxide-eugenol based root canal sealers in human osteoblastic cells. Biomaterials 24 (2003) 1869-1875
6. McNicholas S., Torabinejad M., Blankenship J., and Bakland L. The concentration of prostaglandin E2 in human periradicular lesions. J Endod 17 (1991) 97-100
7. Wang C.Y., Tani-Ishii N., and Stashenko P. Bone-resorptive cytokine gene expression in periapical lesions in the rat. Oral Microbiol Immunol 12 (1997) 65-71
8. Takayama S., Miki Y., Shimauchi H., and Okada H. Relationship between prostaglandin E2 concentrations in periapical exudates from root canals and clinical findings of periapical periodontitis. J Endod 22 (1996) 677-680
9. Shimauchi H., Takayama S., Miki Y., and Okada H. The change of periapical exudate prostaglandin E2 levels during root canal treatment. J Endod 23 (1997) 755-758
10. Oguntebi B.R., Barker B.F., Anderson D.M., and Sakumura J. The effect of indomethacin on experimental dental periapical lesions in rats. J Endod 15 (1989) 117-121
11. Barden J., Edwards J.E., McQuay H.J., and Moore R.A. Single dose oral celecoxib for postoperative pain. Cochrane Database Syst Rev (2003) CD004233
12. Gopikrishna V., and Parameswaran A. Effectiveness of prophylactic use of rofecoxib in comparison with ibuprofen on postendodontic pain. J Endod 29 (2003) 62-64
13. Rappaport H.M., Lilly G.E., and Kapsimalis P. Toxicity of endodontic filling materials. Oral Surg Oral Med Oral Pathol 18 (1964) 785-802
14. Huang F.M., Tsai C.H., Yang S.F., and Chang Y.C. Induction of interleukin-6 and interleukin-8 gene expression by root canal sealers in human osteoblastic cells. J Endod 31 (2005) 679-683
15. Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R., et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390 (1997) 175-179
16. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 165-176
17. Suda K., Udagawa N., Sato N., Takami M., Itoh K., Woo J.T., et al. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation. J Immunol 172 (2004) 2504-2510
18. Okada Y., Lorenzo J.A., Freeman A.M., Tomita M., Morham S.G., Raisz L.G., et al. Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J Clin Invest 105 (2000) 823-832
19. Maruyama K., Takada Y., Ray N., Kishimoto Y., Penninger J.M., Yasuda H., et al. Receptor activator of NF-kappaB ligand and osteoprotegerin regulate proinflammatory cytokine production in mice. J Immunol 177 (2006) 3799-3805
20. Rossa C., Ehmann K., Liu M., Patil C., and Kirkwood K.L. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells. J Interferon Cytokine Res 26 (2006) 719-729
21. Dinchuk J.E., Car B.D., Focht R.J., Johnston J.J., Jaffee B.D., Covington M.B., et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378 (1995) 406-409
22. Lim H., Paria B.C., Das S.K., Dinchuk J.E., Langenbach R., Trzaskos J.M., et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91 (1997) 197-208
23. Okada Y., Pilbeam C., Raisz L., and Tanaka Y. Role of cyclooxygenase-2 in bone resorption. J Uoeh 25 (2003) 185-195
24. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) e45
25. McGettigan P., Henry D., Brophy J.M., Klasser G.D., and Epstein J. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 296 (2006) 1633-1644
26. Zou W., and Bar-Shavit Z. Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 17 (2002) 1211-1218
27. Hong C.Y., Lin S.K., Kok S.H., Cheng S.J., Lee M.S., Wang T.M., et al. The role of lipopolysaccharide in infectious bone resorption of periapical lesion. J Oral Pathol Med 33 (2004) 162-169
28. Igarashi K., Woo J.T., and Stern P.H. Effects of a selective cyclooxygenase-2 inhibitor, celecoxib, on bone resorption and osteoclastogenesis in vitro. Biochem Pharmacol 63 (2002) 523-532
29. Wada N., Maeda H., Yoshimine Y., and Akamine A. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha. Bone 35 (2004) 629-635
30. Tanaka H., Tanabe N., Shoji M., Suzuki N., Katono T., Sato S., et al. Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts. Life Sci 78 (2006) 1733-1740
31. Suda K., Woo J.T., Takami M., Sexton P.M., and Nagai K. Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. J Cell Physiol 190 (2002) 101-108
32. Jiang Y., Mehta C.K., Hsu T.Y., and Alsulaimani F.F. Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. Infect Immun 70 (2002) 3143-3148
33. Jiang J., Li H., Fahid F.S., Filbert E., Safavi K.E., Spangberg L.S., et al. Quantitative analysis of osteoclast-specific gene markers stimulated by lipopolysaccharide. J Endod 32 (2006) 742-746
34. Katagiri T., and Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8 (2002) 147-159